Farxiga for Type 2 diabetes: every route to paying for it

The routes, in order

1. 1

   Why this drug and this condition are paired

   As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

   From the Indications and Usage text of the drug's FDA label. A label naming a condition is not a statement that the drug is approved, effective or covered for you.

   Label on openFDA, read 2026-11-10 · receipt

2. 2

   Medicare Part D: the yearly out-of-pocket threshold

   Found in our data
   CMS prints the Part D out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026).

   A benefit parameter of the standard Part D benefit. It applies to covered drugs under plan rules and is not a prediction of what you will pay. Your plan's formulary decides whether this drug is covered: check a formulary.

   CMS Table V-2, read 2026-11-08

3. 3

   Medicare negotiated price

   Found in our data
   CMS lists $183.33 for a 30-day supply, effective 2027-01-01.

   The price CMS lists for the drug, not what you pay. What you pay depends on your plan and your cost sharing.

   CMS negotiated prices, read 2026-11-06

4. 4

   Manufacturer and foundation programs

   Found in our data
   • Farxiga Savings (via AstraZeneca) status not recorded
   • Heart Medication Assistance (Multiple Programs) status not recorded
   • Diabetes Medication Assistance (Multiple Programs) status not recorded
   • AZ&Me Prescription Savings Program receipt Not in its current list The program's page printed this drug in an earlier list and not in its current one.

   A status is what the program's page says about taking applications, not whether you qualify. Each program has its own eligibility rules.

5. 5

   Charitable funds for Type 2 diabetes

   Found in our data
   We hold 3 funds for Type 2 diabetes: 0 open and 3 not open, read 2026-11-08.

   Every fund, with its award level, insurance supported and source, is on the Type 2 diabetes page. A fund pays for a condition's costs, not necessarily this drug.

6. 6

   Clinical trial access

   Found in our data
   ClinicalTrials.gov lists 98 recruiting interventional trials that name this ingredient (read 2026-11-07).

   A trial is research, not treatment access for everyone, and a listing is not a recommendation.

   ClinicalTrials.gov, read 2026-11-07 · receipt

Questions